Animal Health Partnering | Boehringer Ingelheim

Partnering for future innovation in animal health

We know the combined power of innovation and collaboration can quickly revolutionize animal health. Our collective success in addressing unmet needs in animal health hinges on connecting with partners across the scientific community, so together we can pursue science and solutions and build a healthier future for animals.

200+

Collaborations worldwide contributing to our pipeline and portfolio

8 out of 10

Top-selling products anchored in partner collaborations

€500 million

Investment in R&D for future innovations in animal health

30%

Of our Pipeline anchored in external innovation

Collaboration driving innovation

We focus on delivering breakthrough innovation—wherever it originates—to tackle the most important scientific challenges we face. That’s why we’re one of the industry’s leading investors in animal health innovation. We’re investing in both external innovation and our own R&D to power our research and collectively provide solutions for some of the biggest challenges in animal health.

Therapeutic vaccines: Applying innovative science to tackle chronic disease in pets

We’re embracing disruptive technology to work towards providing solutions for some of the biggest challenges in animal health. One of these challenges is tackling chronic disease in pets. Find out why we’re exploring therapeutic vaccines to help our pets live longer, healthier lives.

Animal Health Partnering and Innovation Outlook 2026

2025 was a year of deal-making, deepening relationships with partners and strengthening connections with human pharma colleagues. Megan Grether, Global Head of Business Development & Licensing, Animal Health and Peter Florian, Head of Research, Animal Health, share their perspectives and look forward to the opportunities that will fuel our momentum in 2026.

Where to Meet Us in 2026

We believe this is an exciting time in animal health with innovative science and groundbreaking solutions set to revolutionize treatment and care. However, there are still many unmet needs that make building connections within the animal health and broader scientific communities ever more crucial. Come and meet us and let’s work together to build a healthier future for animals.

Therapeutic vaccines: Applying innovative science to tackle chronic disease in pets

Animal Health Partnering and Innovation Outlook 2026

Where to Meet Us in 2026

Therapeutic vaccines: Applying innovative science to tackle chronic disease in pets

This year, we're focusing on partnering opportunities in oncology, oral health and central nervous system diseases. We're also seeking later-stage collaborations to complement our internal portfolio in infectious diseases, cardiovascular, renal and skin diseases and obesity.

Synergies across animal and human health

At Boehringer Ingelheim, we’ve seen how learning from each other can accelerate innovation in both human and animal health. Our continued success in addressing unmet needs in animal health relies not only on internal collaboration but also on working with external partners in animal health and human pharma, who bring valuable new ideas and new science to our collective innovation journey. Watch our Beyond Boundaries video to find out more.

Connect with us

We’re excited to hear your ideas. Connect with our Animal Health Partnering team by email, through our online portal, or at an industry event.

Related press releases

Boehringer Ingelheim and Eko Health Inc. enter digital health collaboration to improve heart murmur detection in dogs

June 10, 2025

Boehringer Ingelheim and Eko Health Inc. enter digital health collaboration to improve heart murmur detection in dogs

Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio

September 03, 2024